1. World Health Organization. Global tuberculosis report 2018. Geneva: World Health Organization; 2018.
2. Weisenberg SA, Gibson AL, Huard RC, Kurepina N, Bang H, Lazzarini LC, et al. Distinct clinical and epidemiological features of tuberculosis in new York City caused by the RDRio mycobacterium tuberculosis sublineage. Infect Genet Evol. 2014;27:380–92.
3. David S, Duarte EL, Leite CQF, Ribeiro JN, Maio JN, Paixão E, et al. Implication of the RDRio mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal. Infect Genet Evol. 2012;12:1362–7.
https://doi.org/10.1016/j.meegid.2012.04.021
.
4. Gibson AL, Huard RC, Gey Van Pittius NC, Lazzarini LCO, Driscoll J, Kurepina N, et al. Application of sensitive and specific molecular methods to uncover global dissemination of the major RDRio sublineage of the Latin American-Mediterranean mycobacterium tuberculosis spoligotype family. J Clin Microbiol. 2008;46:1259–67.
5. Reynaud Y, Millet J, Rastogi N. Genetic structuration, demography and evolutionary history of mycobacterium tuberculosis LAM9 sublineage in the Americas as two distinct subpopulations revealed by Bayesian analyses. PLoS One. 2015;10:1–15.